Navigation Links
The Protein Tomography(TM) Award Now Published on Sidec's Homepage
Date:5/26/2008

STOCKHOLM, May 26 /PRNewswire/ -- Sidec announces that the application form for the 2008 Protein Tomography(TM) Award is now available at Sidec's homepage. The winning application will be offered a Protein Tomography(TM) study in collaboration with Sidec. A Protein Tomography(TM) study is typically in the range of 0.1 and 0.5 million Euro and will be funded by Sidec.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/294289 )

The Protein Tomography(TM) Award 2008 is given to acknowledge innovative project ideas in the areas of protein therapeutics and antibody drug development.

A committee chaired by Sidec's CSO Dr. Anders Aberg will select the winning Protein Tomography(TM) project according to the following criteria:

- Biological question of scientific significance and/or commercial

relevance

- Strategically important for the applying company

- With the aim to be published at a time mutually agreed upon

- Technically suitable for Protein Tomography(TM)

Only research groups in the biopharmaceutical industry who have not yet worked with Sidec are eligible for the Award to get acquainted with Protein Tomography(TM).

Please visit http://www.sidec.com to apply. Deadline for Application is July 31, 2008

"I had an excellent experience collaborating with Sidec and utilizing their Protein Tomography(TM) technology. I welcome this Award as a positive step to expose research groups in the biopharmaceutical industry to this revolutionary technology. At UCB we used Protein Tomography(TM) to image the synaptic vesicle of protein 2A in situ. To my knowledge this is the only method available today where it is possible to visualize 3-D images of individual molecules in situ," says Berkley Lynch, previously Principal Investigator at UCB.

About Sidec AB:

Sidec studies molecular interactions in situ and in vitro using its proprietary technology Protein Tomography(TM). Sidec offers collaborative research projects to the biopharmaceutical industry that reveal unique information to prioritize the most promising therapeutic antibody and to locate the antibody binding epitope.

http://www.sidec.com


'/>"/>
SOURCE Sidec AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
4. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
7. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
8. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
11. Immune system protein starves staph bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):